Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210, USA.
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):3-7. doi: 10.1016/j.mce.2010.04.027. Epub 2010 May 6.
Carney complex (CNC) is an inherited tumor predisposition associated with pituitary tumors, including GH-producing pituitary adenomas and rare reports of prolactinomas. This disease is caused by mutations in PRKAR1A, which encodes the type 1A regulatory subunit of the cAMP-dependent protein kinase, PKA. Loss of PRKAR1A causes enhanced PKA signaling, which leads to pituitary tumorigenesis. Mutations in the gene have not been detected in sporadic pituitary tumors, but there is some data to suggest that non-genomic mechanisms may cause loss of protein expression. Unlike CNC patients, mice heterozygous for Prkar1a mutations do not develop pituitary tumors, although complete knockout of the gene in the Pit1 lineage of the pituitary produces GH-secreting pituitary adenomas. These data indicate that complete loss of Prkar1a/PRKAR1A is able to cause pituitary tumors in mice and men. The pattern of tumors is likely related to the signaling pathways employed in specific pituitary cell types.
卡尼复合征(CNC)是一种与垂体瘤相关的遗传性肿瘤易感性疾病,包括生长激素分泌型垂体腺瘤和罕见的催乳素瘤报告。该病由 PRKAR1A 基因突变引起,该基因编码 cAMP 依赖性蛋白激酶(PKA)的 I 型调节亚基。PRKAR1A 的缺失导致 PKA 信号转导增强,从而导致垂体肿瘤发生。散发性垂体瘤中未检测到该基因的突变,但有一些数据表明非基因组机制可能导致蛋白表达缺失。与 CNC 患者不同,PRKAR1A 基因突变杂合子的小鼠不会发生垂体瘤,尽管垂体中 Pit1 谱系的基因完全缺失会导致生长激素分泌型垂体腺瘤。这些数据表明,PRKAR1A 的完全缺失能够在小鼠和人类中引起垂体瘤。肿瘤的模式可能与特定垂体细胞类型中使用的信号通路有关。